XLRN

Acceleron Pharma
XLRN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

79 hedge funds and large institutions have $593M invested in Acceleron Pharma in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$46.9M
2
+$28.2M
3
+$27.6M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$9.95M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$8.75M

Top Sellers

1
-$8.97M
2
-$8.62M
3
-$2.74M
4
VOYA Investment Management
VOYA Investment Management
Georgia
-$2.59M
5
DCM
Driehaus Capital Management
Illinois
-$2.53M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.17M
27
$1.99M
28
$1.92M
29
$1.9M
30
$1.74M
31
$1.37M
32
$1.28M
33
$1.13M
34
$1.08M
35
$994K
36
$992K
37
$937K
38
$809K
39
$799K
40
$793K
41
$775K
42
$721K
43
$704K
44
$690K
45
$621K
46
$592K
47
$569K
48
$562K
49
$547K
50
$494K
1
2
3 4